Torbjörn Callréus. Show Affiliations »
Abstract
Mesh: See more » Adverse Drug Reaction Reporting Systems/organization & administrationCardiovascular Diseases/chemically inducedCost-Benefit AnalysisDrug ApprovalHumansLactones/adverse effectsSulfones/adverse effects
Substances: See more » LactonesSulfonesrofecoxib
Year: 2005 PMID: 15677673 PMCID: PMC546118 DOI: 10.1136/bmj.330.7485.255-c
Source DB: PubMed Journal: BMJ ISSN: 0959-8138